Journals / Turkish Journal of Urology / 2020 / Cilt: 46 - Sayı: 3

Trends in the incidence rate of genitourinary system cancers in Turkey: 2004–2015

Pages
196–205
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While there was no cancer with decreased incidence during the entire study period, similar decreases in some urogenital cancer types tended to occur during the second trend period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To analyze age-standardized urological cancer incidence rates in Turkey during the last twelve years based on the available published data (2004–2015).Material and methods: Cancer data were obtained from the reports of Turkish Directorate of Public Health Cancer Department for 2004–2015.
📊
Key Findings & Data:The average annual percentage of change, annual percent change, and the corresponding 95% confidence interval were calculated.Results: Throughout the observed period, cancer incidence rates in men significantly increased by 3.04%, 4.70%, 4.03%, and 2.97% for all the genital organs, kidney, testis, and prostate, respectively.
💡
Conclusion & Impact:While there was no cancer with decreased incidence during the entire study period, similar decreases in some urogenital cancer types tended to occur during the second trend period.
🔬Design:Research Article
📍Scope:2004–2015 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: To analyze age-standardized urological cancer incidence rates in Turkey during the last twelve years based on the available published data (2004–2015).Material and methods: Cancer data were obtained from the reports of Turkish Directorate of Public Health Cancer Department for 2004–2015. A trend analysis was conducted using the joinpoint regression analysis to observe the change in the trends over time. The average annual percentage of change, annual percent change, and the corresponding 95% confidence interval were calculated.Results: Throughout the observed period, cancer incidence rates in men significantly increased by 3.04%, 4.70%, 4.03%, and 2.97% for all the genital organs, kidney, testis, and prostate, respectively. A significant increase of 3.11% and 1.91% was observed for the urinary system organs and bladder, respectively, of women during the same period.Conclusion: The increase in the incidence rate of urinary system cancers was more prominent than that of all cancers types in general. The total incidence rate of urinary system cancers (bladder and kidney) tends to increase more in women than in men. While there was no cancer with decreased incidence during the entire study period, similar decreases in some urogenital cancer types tended to occur during the second trend period.

🔖

Cite This Article

YİĞİT, P., ATAÇ, Ö., AYDIN, S. (2020). Trends in the incidence rate of genitourinary system cancers in Turkey: 2004–2015. Turkish Journal of Urology, Cilt: 46 - Sayı: 3, 196–205. https://ajindex.com/articles/379773

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018
  2. [CrossRef] 2. The Turkish Statistical Institute. Date Rate Statistics [Internet]. TUIK2019 [cited 2019 Nov 5]. Available from: http://www.tuik.gov.tr/PreTablo.do?alt_id=1083 3. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001
  3. [CrossRef] 4. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999
  4. [CrossRef] 5. Aydın S, Boz MY. Rapid changes in the incidence of urinary system cancers in Turkey. Turk J Urol 2015
  5. [CrossRef] 6. Yilmaz HH, Yazihan N, Tunca D, Sevinç A, Olcayto EÖ, Özgül N, et al. Cancer trends and incidence and mortality patterns in Turkey. Jpn J Clin Oncol 2011
  6. [CrossRef] 7. Türkiye kanser istatistikleri. 2015
  7. Available from: https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/istatistik/Turkiye_Kanser_Istatistikleri_2015.pdf 8. International Agency for Research on Cancer. Globocan 2018,Turkey. 2018
  8. Available from: http://gco.iarc.fr/today/data/factsheets/populations/792-turkey-fact-sheets.pdf 9. T.C. Halk Sağlığı Kurumu. Türkiye Kanser istatistikleri 2015. TC Sağlık Bakanlığı Halk Sağlığı Müdürlüğü [Internet] 2018
  9. Available from: https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/istatistik/Turkiye_Kanser_Istatistikleri_2015.pdf 10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010
  10. [CrossRef] 11. Parkin D, Max M, Freddie BJF, Pisani Paola P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005
  11. [CrossRef] 12. Joinpoint Regression Program [Internet]. [cited 2020 Jan 21]. Available from: https://surveillance.cancer.gov/joinpoint/ 13. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joipoint regression with applications to cancer rates. Stat Med 2000
  12. [CrossRef] 14. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med 2009
  13. [CrossRef] 15. T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu Kanser Daire Başkanlığı. Türkiye Kanser Kontrol Programı. T.C. Sağlık Bakanlığı. Türkiye Halk Sağlığı Kurumu Kanser Daire Başkanlığı 2016
  14. Available from: https://hsgm.saglik.gov.tr/depo/birimler/k